Sodium-glucose cotransporter 2 inhibitors and the risk of kidney cancer among patients with type 2 diabetes - a population-based cohort study
Favorite
Share
More Options
13

Open in WPS to view all 13 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
